ArticleInternational journal of women's health2026
Rapid Intrauterine Fetal Death Caused by
Article in International journal of women's health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Case Presentation: A 34-year-old primigravida at 22+6 weeks presented after 8 hours of fever and 6 hours of lower abdominal pain. Marked leukocytosis, neutrophilia, elevated C-reactive protein, fetal tachycardia, uterine contractions, and abnormal amniotic echogenicity suggested intra-amniotic infection. Ceftriaxone was started for fever of undetermined origin; intrauterine fetal death occurred 8 hours after admission. Cultures of throat swab, ear swab, and perianal secretion specimens obtained from the delivered fetus all yielded Conclusion: In febrile pregnant patients, the combination of fetal tachycardia, uterine activity, a marked inflammatory response, and no alternative infection source should prompt early consideration of listeriosis and LM-active empirical therapy after cultures are obtained. Dietary exposure history, appropriate specimen collection, and awareness of cephalosporin noncoverage are central to management and prevention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.